Compare NIO Inc. (NIO) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NIO Inc. vs Smith & Nephew plc — how do they compare? NIO Inc. trades at $3.58 (market cap $8.62B), while Smith & Nephew plc trades at $27.24 (market cap $11.10B). The key difference: Smith & Nephew plc is the larger of the two by market cap, and Smith & Nephew plc pays a 2.95% dividend while NIO Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold NIO Inc. for 81 Days and Smith & Nephew plc for 121 Days on average.
| NIO | SNN | |
|---|---|---|
Market Cap | $8.62B | $11.10B |
Volume | 39,648,517 | 1,051,703 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.42 | $37.17 |
52-Week Low | $3.37 | $26.42 |
Typical Hold Time | 81 Days | 121 Days |
Enterprise Value | $6.52B | $14.13B |
Dividend Yield | — | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NIO trades at $3.41, down 3.67% today and near its 52-week low of $3.38. The stock shows bearish technical signals with negative moving averages, though recent quarterly earnings have consistently beaten expectations. Revenue growth remains strong at $87.49 billion for 2025, but profitability challenges persist with a net loss of $15.57 billion. The recent Geely battery-swap partnership provides strategic expansion potential while raising questions about near-term profitability.
NIO presents a high-risk opportunity with significant upside potential given the $6.23 consensus price target, but faces substantial execution risks in China's competitive EV market. While analyst sentiment leans bullish with 50% buy ratings, investors must weigh strong revenue growth against persistent losses and negative cash flow trends before considering position entry.
Smith+Nephew (SNN) trades at $26.96, near its 52-week low, with bearish technical signals despite recent earnings beats. The company shows strong fundamentals with revenue growth to $6.16B in 2025 and improving profit margins of 10.08%. Recent product launches in trauma care and surgical robotics highlight innovation, but analyst sentiment remains cautious with 65% hold ratings.
Investment outlook is mixed: solid fundamentals and product pipeline offer upside, but technical weakness and analyst skepticism pose near-term risks. Key catalysts include execution on new product adoption and margin expansion, while risks involve competitive pressures and leadership transitions following the CFO's departure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
